close
close

FDA expands approval for drug to treat early-stage breast cancer

IE 11 is not supported. For an optimal experience, please visit our site with another browser.

  • Forest fires in Portugal kill several people

    02:46

  • Now running

    FDA expands approval for drug to treat early-stage breast cancer

    01:31

  • Next

    Judge denies bail for Sean “Diddy” Combs after he pleaded not guilty

    05:39

  • Meet Douyin, the Chinese version of TikTok that contributes to ByteDance's big business

    04:30

  • Baltimore takes on pharmaceutical companies in opioid lawsuit to curb overdoses

    04:32

  • Hearing on submersible Titan begins, new pictures of the wreck released

    03:41

  • Pipeline explosion in Texas forces thousands to evacuate

    02:45

  • Several states are expanding insurance coverage to support illegal immigrants

    02:56

  • Boeing threatens strike as workers vote on new collective agreement

    03:36

  • Alaska Airlines plane aborts takeoff to avoid collision with Southwest jet

    02:18

  • Louisiana governor ‘works tirelessly’ to restore power

    04:55

  • Scientists are studying the “Parkinson Belt” and assume that the disease is related to chemicals

    04:56

  • In one of the few remaining clinics that perform abortions in later pregnancy

    05:22

  • NBC News reporter reports how Mississippi residents are preparing for Francine

    01:58

  • Louisiana Sheriff calls Hurricane Francine “worst storm in a long time”

    03:25

  • Hurricane Francine upgraded to Category 2

    07:54

  • Can AI help families make difficult decisions about end-of-life care?

    03:23

  • CDC confirms first human case of bird flu in Missouri

    01:04

  • Former Vice President Dick Cheney will vote for Harris, says his daughter Liz Cheney

    02:32

  • Trump's team is courting the support of young men as the gender gap widens

    04:22

The US Food and Drug Administration has expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients in earlier stages of the disease. NBC News' Kathy Park speaks with a woman who took the drug during clinical trials and is now cancer-free.